E-Selectin and restenosis after femoropopliteal angioplasty: Prognostic impact of the Ser128Arg genotype and plasma levels

Thrombosis and Haemostasis

Volumn 91, Issue 1, 2004, Pages 171-179

  Mlekusch, Wolfgang ^a   Exner, Markus ^a   Schillinger, Martin ^a   Sabeti, Schila ^a   Mannhalter, Christine ^a   Minar, Erich ^a   Wagner, Oswald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angioplasty; E Selectin; Genes; Polymorphism; Restenosis

Indexed keywords

ARGININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; SERINE;

AGED; ARTERY DISEASE; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMORAL ARTERY; FOLLOW UP; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERMITTENT CLAUDICATION; LEUKOCYTE ADHERENCE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; POPLITEAL ARTERY; POSTOPERATIVE THROMBOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK; TREATMENT FAILURE; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; WILD TYPE;

EID: 1642515070     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-06-0402     Document Type: Article

References (34)

1. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). Eur J Vasc Endovasc Surg 2000; 19: S1-S250.
2. Varty K, Bolia A, Naylor AR et al. Infrapopliteal percutaneous transluminal angioplasty: A safe and successful procedure. Eur J Vasc Surg 1995; 9: 341-5.
3. Morgenstern BR, Getraidmann GJ, Laffey KJ et al. Total occlusions of the femoropopliteal artery: High technical success rate of conventional balloon angioplasty. Radiology 1989; 172: 937-40.
4. Tsakiris DA, Tschöpl M, Jaeger K et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142: 193-200.
5. Waller BF, Pingkerton CA, Orr CM et al. Morphological observations late (>30°) after clinically successful coronary balloon angioplasty in the atherosclerotic rabbit. Circulation 1991; 83: 28-41.
6. Belch JJF, Shaw JW, Kirk G et al. The white blood cell adhesion molecule E-Selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 1997; 95: 2027-31.
7. McBride W, Lange RA, Hillis DL. Restenosis after successful coronary angioplasty: Pathophysiology and prevention. N Engl J Med 1988; 318: 1734-7.
8. Frenette PS, Wagner DD. Adhesion molecules, I. N Engl J Med 1996; 334: 1526-9.
9. Frenette PS, Wagner DD. Adhesion molecules, II. N Engl J Med 1996; 335: 43-5.
10. Barron MK, Scott Lake R, Buda AJ, et al. Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation 1997; 96: 3587-92.
11. Inoue T, Hoshi K, Yaguchi I, et al. Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 1999; 91: 236-42.
12. Wenzel K, Felix S, Kleber FX, et al. E-Selectin polymorphism and atherosclerosis: An association study. Hum Mol Genet 1994; 3: 1935-7.
13. Wenzel K, Ernst M, Rohde K, et al. DANN polymorphism in adhesion molecule genes - A new risk factor for early atherosclerosis. Hum Genet 1996; 97: 15-20.
14. Rauchhaus M, Gross M, Schulz S, et al. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int J Card 2002; 83: 249-57.
15. Bevilacqua MP, Stengelin S, Gimbrone MAJ, et al. Endothelial leucocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-5.
16. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stentimplantation induce a vascular inflammatory reaction. J Endovasc Ther 2002; 9: 59-66.
17. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: Association with restenosis. Radiology 2002; 225: 21-6.
18. Schillinger M, Exner M, Mlekusch W, et al. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries. Thromb Haemost 2002; 87: 959-65.
19. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and Risk of Developing peripheral vascular disease. Circulation 1998; 97: 425-8.
20. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: Correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992; 18: 443-40.
21. Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection. Nucleic Acids Res 1993; 21: 3623-9.
22. Ferri C, Desideri G, Baldoncini R, et al. Early activation of vascular endothelium in non-obese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 1998; 47: 660-7.
23. Ellsworth DL, Bielack LF, Turner ST, et al. Gender- and age-dependent relationship between the E-Selectin S128R polymorphism and coronary artery calcification. J Mol Med 2001; 79: 390-8.
24. Caulin-Glaser T, Farrel WJ, Pfau SE, et al. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J Am Coll Cardiol 1998; 31: 1555-60.
25. Gordon DJ, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977; 62: 707-14.
26. Stannard AK, Khan S, Graham A, et al. Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells. Atherosclerosis 2001; 154: 31-8.
27. Cockerill GW, Rye KA, Gamble JR, et al. High-density lipoproteins inhibit cytocine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987-94.
28. Tsakiris DA, Tschöpl M, Jäger K, et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142: 193-200.
29. Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecules-1 and E-Selectin levels in relation to vascular risk factors and to E-Selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 1998; 41: 460-6.
30. Ray KK, Camp NJ, Bennett CE, et al. Genetic variation at the interlaukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes. Clin Science 2002; 103: 303-10.
31. Bauters C, Lamblin N, Amouyel P. Gene polymorphisms and outcome after coronary angioplasty. Curr Interv Cardiol Rep. 2001; 3: 281-6.
32. Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001; 8: 443-40.
33. Johnston KW. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 1992; 183: 767-71.
34. Schillinger M, Mlekusch W, Haumer M, et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther 2003; 10: 288-97.